Type(s) of Cancer
Prostate
Prostate
Study Phase
Phase 3
Study Completion Date
2006
2006
NCT00519285NCT00273338NCT00988208Uploaded 04-08-2016
Available for Download
PDS UID: Prostat_na_2006_149
Prostate Cancer DREAM Challenge data sets
PDS UID: Prostat_Celgene_2009_90Go to Study
A Phase 3 Study to Evaluate the Efficacy and Safety of Docetaxel and Prednisone with or without Lenalidomide in Subjects with Castrate-Resistant Prostate Cancer
PDS UID: Prostat_Novacea_2006_89Go to Study
A Phase 3, Randomized, Open-Label Study Evaluating DN-101 in Combination with Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (ASCENT-2)
PDS UID: Prostat_Sanofi_2007_83Go to Study
(VENICE) A Multicenter, Randomized, Double-Blind Study Comparing the Efficacy and Safety of Aflibercept Versus Placebo Administered Every 3 Weeks in Patients Treated with Docetaxel / Prednisone for Metastatic Androgen-Independent Prostate Cancer
Files:
PROTOCOLNot Provided
CRFPCDC Protocol, CRF Location.docx
DATA DICTIONARYChallenge_data_dictionary v2.xlsx
DATA (COMPARATOR ARM)prostate_cancer_challenge_data_finalscoringset.zip
DATA (COMPARATOR ARM)prostate_cancer_challenge_data_leaderboard.zip
DATA (COMPARATOR ARM)prostate_cancer_challenge_data_training.zip